These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 37514998)

  • 1. Designing a Multi-Epitope Subunit Vaccine against VP1 Major Coat Protein of JC Polyomavirus.
    Kanse S; Khandelwal M; Pandey RK; Khokhar M; Desai N; Kumbhar BV
    Vaccines (Basel); 2023 Jun; 11(7):. PubMed ID: 37514998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Broadly neutralizing human monoclonal JC polyomavirus VP1-specific antibodies as candidate therapeutics for progressive multifocal leukoencephalopathy.
    Jelcic I; Combaluzier B; Jelcic I; Faigle W; Senn L; Reinhart BJ; Ströh L; Nitsch RM; Stehle T; Sospedra M; Grimm J; Martin R
    Sci Transl Med; 2015 Sep; 7(306):306ra150. PubMed ID: 26400911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progressive multifocal leukoencephalopathy-associated mutations in the JC polyomavirus capsid disrupt lactoseries tetrasaccharide c binding.
    Maginnis MS; Ströh LJ; Gee GV; O'Hara BA; Derdowski A; Stehle T; Atwood WJ
    mBio; 2013 Jun; 4(3):e00247-13. PubMed ID: 23760462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human iPS cell-derived astrocytes support efficient replication of progressive multifocal leukoencephalopathy-type JC polyomavirus.
    Shimbo E; Nukuzuma S; Tagawa YI
    Biochem Biophys Res Commun; 2020 Dec; 533(4):983-987. PubMed ID: 33008586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ERK Is a Critical Regulator of JC Polyomavirus Infection.
    DuShane JK; Wilczek MP; Mayberry CL; Maginnis MS
    J Virol; 2018 Apr; 92(7):. PubMed ID: 29321332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New sequence polymorphisms in the outer loops of the JC polyomavirus major capsid protein (VP1) possibly associated with progressive multifocal leukoencephalopathy.
    Zheng HY; Takasaka T; Noda K; Kanazawa A; Mori H; Kabuki T; Joh K; Oh-Ishi T; Ikegaya H; Nagashima K; Hall WW; Kitamura T; Yogo Y
    J Gen Virol; 2005 Jul; 86(Pt 7):2035-2045. PubMed ID: 15958683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of a pore in the capsid of JC polyomavirus reduces infectivity and prevents exposure of the minor capsid proteins.
    Nelson CD; Ströh LJ; Gee GV; O'Hara BA; Stehle T; Atwood WJ
    J Virol; 2015 Apr; 89(7):3910-21. PubMed ID: 25609820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cloning of the first human anti-JCPyV/VP1 neutralizing monoclonal antibody: epitope definition and implications in risk stratification of patients under natalizumab therapy.
    Diotti RA; Mancini N; Clementi N; Sautto G; Moreno GJ; Criscuolo E; Cappelletti F; Man P; Forest E; Remy L; Giannecchini S; Clementi M; Burioni R
    Antiviral Res; 2014 Aug; 108():94-103. PubMed ID: 24909571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. JC Polyomavirus Infection Reveals Delayed Progression of the Infectious Cycle in Normal Human Astrocytes.
    Wilczek MP; DuShane JK; Armstrong FJ; Maginnis MS
    J Virol; 2020 Feb; 94(5):. PubMed ID: 31826993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. JCPyV VP1 Mutations in Progressive MultifocalLeukoencephalopathy: Altering Tropismor Mediating Immune Evasion?
    Lauver MD; Lukacher AE
    Viruses; 2020 Oct; 12(10):. PubMed ID: 33053912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies reacting with JCPyV_VP2 _167-15mer as a novel serological marker for JC polyomavirus infection.
    Lagatie O; Van Loy T; Tritsmans L; Stuyver LJ
    Virol J; 2014 Oct; 11():174. PubMed ID: 25273879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low frequency of cytotoxic T lymphocytes against the novel HLA-A*0201-restricted JC virus epitope VP1(p36) in patients with proven or possible progressive multifocal leukoencephalopathy.
    Du Pasquier RA; Kuroda MJ; Schmitz JE; Zheng Y; Martin K; Peyerl FW; Lifton M; Gorgone D; Autissier P; Letvin NL; Koralnik IJ
    J Virol; 2003 Nov; 77(22):11918-26. PubMed ID: 14581528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum IgG antibodies from healthy subjects up to 100 years old react to JC polyomavirus.
    Bononi I; Mazzoni E; Pietrobon S; Manfrini M; Torreggiani E; Rossini M; Lotito F; Guerra G; Rizzo P; Martini F; Tognon M
    J Cell Physiol; 2018 Aug; 233(8):5513-5522. PubMed ID: 29323725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High expression of JC polyomavirus-encoded microRNAs in progressive multifocal leukoencephalopathy tissues and its repressive role in virus replication.
    Takahashi K; Sato Y; Sekizuka T; Kuroda M; Suzuki T; Hasegawa H; Katano H
    PLoS Pathog; 2020 Apr; 16(4):e1008523. PubMed ID: 32324824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interplay of cellular and humoral immune responses against BK virus in kidney transplant recipients with polyomavirus nephropathy.
    Chen Y; Trofe J; Gordon J; Du Pasquier RA; Roy-Chaudhury P; Kuroda MJ; Woodle ES; Khalili K; Koralnik IJ
    J Virol; 2006 Apr; 80(7):3495-505. PubMed ID: 16537617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CPT11 prevents virus replication in JCI cells persistently infected with JC polyomavirus.
    Nukuzuma S; Nukuzuma C; Kameoka M; Sugiura S; Nakamichi K; Tasaki T; Takegami T
    Microbiol Immunol; 2017 Jun; 61(6):232-238. PubMed ID: 28463406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small-molecule inhibitors of JC polyomavirus infection.
    Yatawara A; Gaidos G; Rupasinghe CN; O'Hara BA; Pellegrini M; Atwood WJ; Mierke DF
    J Pept Sci; 2015 Mar; 21(3):236-42. PubMed ID: 25522925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppressive effect of topoisomerase inhibitors on JC polyomavirus propagation in human neuroblastoma cells.
    Nukuzuma S; Nakamichi K; Kameoka M; Sugiura S; Nukuzuma C; Tasaki T; Takegami T
    Microbiol Immunol; 2016 Apr; 60(4):253-60. PubMed ID: 26935240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human Polyomavirus JC monitoring and noncoding control region analysis in dynamic cohorts of individuals affected by immune-mediated diseases under treatment with biologics: an observational study.
    Bellizzi A; Anzivino E; Rodio DM; Cioccolo S; Scrivo R; Morreale M; Pontecorvo S; Ferrari F; Di Nardo G; Nencioni L; Carluccio S; Valesini G; Francia A; Cucchiara S; Palamara AT; Pietropaolo V
    Virol J; 2013 Sep; 10():298. PubMed ID: 24079660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular epidemiology of JC polyomavirus in HIV-infected patients and healthy individuals from Iran.
    Makvandi M; Mombeini H; Haghighi SB; Dastoorpoor M; Khodadad N; Babaahmadi MK; Tabasi M; Pirmoradi R
    Braz J Microbiol; 2020 Mar; 51(1):37-43. PubMed ID: 31364012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.